Literature DB >> 33468174

Elevated expression of MMP8 and MMP9 contributes to diabetic osteoarthritis progression in a rat model.

Simin Luo1, Wuji Li1, Wenrui Wu1, Qiping Shi2.   

Abstract

BACKGROUND: Knowledge regarding the pathogenesis of osteoarthritis (OA) is very limited. Previous studies have shown that matrix metalloproteinase (MMP) 8 and MMP9 were upregulated in patients with diabetic OA. However, their regulatory functions and mechanisms in diabetic OA are not fully understood.
METHODS: Diabetic OA rats were constructed using a high-fat diet combined with streptozotocin (STZ) induction. Safranin O-Fast green staining was used to detect the pathological changes in rat knee cartilage. MMP8 and MMP9 overexpression vectors or siRNAs were injected into diabetic OA rats to overexpress or knockdown the expression of MMP8 and MMP9, which was verified by real-time quantitative PCR (RT-qPCR). The expression of MMP8 and MMP9, chondrocyte differentiation markers collagen type II alpha 1 (COL2A1) and collagen type I alpha 1(COL1A1), and antiapoptotic protein BCL2 were detected using immunohistochemistry (IHC), and the number of apoptotic cells was detected by the transferase-mediated d-UTP nick-end-labeling (TUNEL) assay.
RESULTS: High-fat diet combined with STZ-induced rats exhibited joint cartilage damage, morphological changes, and increased expression of MMP8 and MMP9. Overexpression of MMP8 and MMP9 in the joint cavity further aggravated the pathological morphological changes, decreased the expression of COL2A1 and COL1A1, increased the expression of BCL2, and promoted cell apoptosis in diabetic OA rats. The use of siRNA to inhibit MMP8 and MMP9 levels in the cartilage joints significantly reversed the decrease in COL2A1 and COL1A1 expression and partially reversed BCL2 expression and chondrocyte apoptosis.
CONCLUSION: MMP8 and MMP9 promoted rat diabetic OA model. The underlying mechanism may be related to inhibiting cartilage differentiation and promoting chondrocyte apoptosis.

Entities:  

Keywords:  Apoptosis; Diabetes; Differentiation; MMP8; MMP9; Osteoarthritis

Mesh:

Substances:

Year:  2021        PMID: 33468174      PMCID: PMC7814732          DOI: 10.1186/s13018-021-02208-9

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  28 in total

Review 1.  Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.

Authors:  Orit Schieir; Cedomir Tosevski; Richard H Glazier; Sheilah Hogg-Johnson; Elizabeth M Badley
Journal:  Ann Rheum Dis       Date:  2017-02-20       Impact factor: 19.103

Review 2.  Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.

Authors:  Agata Jabłońska-Trypuć; Marzena Matejczyk; Stanisław Rosochacki
Journal:  J Enzyme Inhib Med Chem       Date:  2016-03-30       Impact factor: 5.051

Review 3.  Osteoarthritis and type 2 diabetes mellitus: What are the links?

Authors:  Alice Courties; Jérémie Sellam
Journal:  Diabetes Res Clin Pract       Date:  2016-11-05       Impact factor: 5.602

4.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels.

Authors:  P D Benya; J D Shaffer
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

Review 5.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

6.  Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8).

Authors:  Ana Gutiérrez-Fernández; Masaki Inada; Milagros Balbín; Antonio Fueyo; Ana S Pitiot; Aurora Astudillo; Kenji Hirose; Michiko Hirata; Steven D Shapiro; Agnès Noël; Zena Werb; Stephen M Krane; Carlos López-Otín; Xose S Puente
Journal:  FASEB J       Date:  2007-03-28       Impact factor: 5.191

7.  Type 2 diabetes patients have accelerated cartilage matrix degeneration compared to diabetes free controls: data from the Osteoarthritis Initiative.

Authors:  J Neumann; F C Hofmann; U Heilmeier; W Ashmeik; K Tang; A S Gersing; B J Schwaiger; M C Nevitt; G B Joseph; N E Lane; C E McCulloch; T M Link
Journal:  Osteoarthritis Cartilage       Date:  2018-03-29       Impact factor: 6.576

8.  Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.

Authors:  Flavia M Gonçalves; Anna L B Jacob-Ferreira; Valeria A Gomes; Antonio Casella-Filho; Antonio C P Chagas; Andrea M Marcaccini; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Clin Chim Acta       Date:  2009-02-28       Impact factor: 3.786

9.  MMP13 is a critical target gene during the progression of osteoarthritis.

Authors:  Meina Wang; Erik R Sampson; Hongting Jin; Jia Li; Qiao H Ke; Hee-Jeong Im; Di Chen
Journal:  Arthritis Res Ther       Date:  2013-01-08       Impact factor: 5.156

10.  Carnosine Prevents Type 2 Diabetes-Induced Osteoarthritis Through the ROS/NF-κB Pathway.

Authors:  Yue Yang; Yang Wang; Yawei Kong; Xiaoning Zhang; He Zhang; Yi Gang; Lunhao Bai
Journal:  Front Pharmacol       Date:  2018-06-06       Impact factor: 5.810

View more
  1 in total

1.  Immunoregulation and anti-metalloproteinase bioactive injectable polysalicylate matrixgel for efficiently treating osteoarthritis.

Authors:  Xinlin Jia; Junping Ma; Xuzhuo Chen; Wentao Li; Xianhao Zhou; Bo Lei; Xin Zhao; Yuanqing Mao
Journal:  Mater Today Bio       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.